Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
FDA grants appeal and files NDABURLINGTON, Mass., May 01, 2023 Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies to treat central. | May 1, 2023
Company to Host Webcast Wednesday, April 13, 2022 at 11am ETWALTHAM, Mass., April 07, 2022(NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system
Metacognitive training for patients with psychosis can reduce positive and negative symptoms of schizophrenia and should be considered for inclusion in international treatment guidelines, researchers say.
State of the U highlights resilience, future initiatives miami.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miami.edu Daily Mail and Mail on Sunday newspapers.